Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Shionogi
Shionogi
Maze lands new partner for Pompe drug, after Sanofi pact came apart
BioPharma Dive
Fri, 05/10/24 - 11:29 am
Maze Therapeutics
Pompe disease
Shionogi
FTC
Sanofi
MZE001
Obesity: Six trials to watch over the next 12 months
Clinical Trials Arena
Fri, 06/30/23 - 11:45 am
obesity
clinical trials
Novo Nordisk
Altimmune
Innovent Biologics
Pfizer
Shionogi
Tonix
semaglutide
oxytocin
permvidutide
mazdutide
danuglipron
Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline
BioSpace
Mon, 06/26/23 - 08:48 pm
Shionogi
M&A
Qpex Biopharma
antimicrobials
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Shionogi starts global Phase II clinical trial of redasemtide
Clinical Trials Arena
Tue, 04/11/23 - 10:00 am
Shionogi
clinical trials
redasemtide
stroke
Shionogi's COVID-19 antiviral nabs Japanese approval to rival drugs from Pfizer, Merck
Fierce Pharma
Tue, 11/22/22 - 04:28 pm
Shionogi
COVID-19
antivirals
Japan
Shionogi's COVID-19 vaccine matches Pfizer's Comirnaty in booster trial
Fierce Biotech
Fri, 03/4/22 - 09:46 am
Shionogi
vaccines
COVID-19
Japan
Pfizer
Shionogi files for approval of oral COVID-19 antiviral in Japan, brushing off missed clinical endpoint in race to market
Fierce Biotech
Mon, 02/28/22 - 11:19 am
Shionogi
Japan
antivirals
COVID-19
Shionogi licenses out 3rd-gen HIV asset to ViiV, notches a flop in chronic cough
Fierce Biotech
Tue, 09/28/21 - 11:38 pm
Shionogi
HUV
ViiV Healthcare
clinical trials
chronic cough
sivopixant
One year after Fetroja approval, Shionogi expands label to include difficult-to-treat pneumonia
Endpoints
Mon, 09/28/20 - 10:44 pm
Fetroja
Shionogi
hospital-acquired pneumonia
ventilator-associated bacterial pneumonia
FDA
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
PhII Alzheimer's data looming, Shionogi spending up to $500M on a buyout involving one of the toughest bets in biotech
Endpoints
Tue, 05/26/20 - 12:02 pm
Shionogi
Alzheimer's disease
Tetra Therapeutics
M&A
Shionogi boosts Tetra Alzheimer's deal, nabs buyout option
Fierce Biotech
Fri, 03/6/20 - 11:41 pm
Shionogi
Tetra Therapeutics
R&D
M&A
Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'
Endpoints
Tue, 11/26/19 - 11:39 pm
Roche
Xofluza
Japan
Shionogi
Flu
influenza
After positive panel vote, Shionogi antibiotic scores US approval
Endpoints
Fri, 11/15/19 - 10:50 am
Shionogi
antibiotics
FDA
cUTI
UTIs
Fetroja
Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote
Endpoints
Thu, 10/17/19 - 10:28 am
Shionogi
FDA
advisory panels
antibiotics
cefiderocol
UTIs
In-house FDA review flags a suspicious imbalance in deaths as Shionogi hunts an OK for antibiotic
Endpoints
Mon, 10/14/19 - 10:26 am
Shionogi
FDA
advisory panels
antibiotics
UTIs
cefiderocol
Shionogi celebrates antibiotic win in pneumonia just ahead of its date with FDA regulators
Endpoints
Wed, 10/9/19 - 10:39 am
Shionogi
antibiotics
FDA
cefiderocol
nosocomial pneumonia
Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug
Endpoints
Fri, 02/22/19 - 10:17 am
Shionogi
Europe
opioid-induced constipation
Symproic
Rizmoic
Pages
1
2
3
next ›
last »